Lexicon Pharmaceuticals (LXRX) Treasury Shares (2010 - 2026)

Lexicon Pharmaceuticals (LXRX) has 17 years of Treasury Shares data on file, last reported at $2.8 million in Q1 2026.

• Treasury Shares for Q1 2026 came in at $2.8 million, down 45.19% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.8 million (down 45.19% YoY), and the FY2025 annual result was $5.2 million, up 12.39% from the prior year.
• Treasury Shares eased to $2.8 million in Q1 2026 per LXRX's latest filing, from $5.2 million in the prior quarter.
• Over five years, Treasury Shares peaked at $16.3 million in Q2 2025 and troughed at $488000.0 in Q1 2022.
• A 5-year average of $5.1 million and a median of $2.4 million in 2025 frame the typical range for Treasury Shares.
• The sharpest annual moves came in 2022 and 2024: Treasury Shares slumped 72.59% in 2022, then soared 59.97% in 2024.
• A 5-year view of Treasury Shares shows it stood at $2.1 million in 2022, then surged by 39.98% to $2.9 million in 2023, then soared by 59.97% to $4.6 million in 2024, then rose by 12.39% to $5.2 million in 2025, then tumbled by 45.19% to $2.8 million in 2026.
• Business Quant data shows LXRX's Treasury Shares at $2.8 million in Q1 2026, $5.2 million in Q4 2025, and $5.2 million in Q3 2025.